X4 Pharmaceuticals (XFOR) Share-based Compensation Growth (1y) (2018 - 2025)
X4 Pharmaceuticals (XFOR) Share-based Compensation Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.48 Mn | -49.57 Mn | 2.20 Mn | 2.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.44% |
| Sep 30, 2025 | -58.24% |
| Jun 30, 2025 | -69.19% |
| Mar 31, 2025 | -70.16% |
| Dec 31, 2024 | -12.68% |
| Sep 30, 2024 | -22.91% |
| Jun 30, 2024 | 13.35% |
| Mar 31, 2024 | 5.71% |
| Dec 31, 2023 | -51.05% |
| Sep 30, 2023 | 179.52% |
| Jun 30, 2023 | -27.85% |
| Mar 31, 2023 | 13,608.33% |
| Dec 31, 2022 | 222.37% |
| Sep 30, 2022 | -295.84% |
| Jun 30, 2022 | -2.82% |
| Dec 31, 2021 | 15.09% |
| Sep 30, 2021 | -62.25% |
| Jun 30, 2021 | 610.02% |
| Sep 30, 2020 | 677.84% |
| Jun 30, 2020 | -238.34% |